Recombinant Human B3GNT7 Protein ，His & Myc

B3GNT7, or Beta-1,3-N-acetylglucosaminyltransferase 7, is an enzyme that plays a critical role in the biosynthesis of glycoproteins and glycolipids by catalyzing the transfer of N-acetylglucosamine (GlcNAc) residues to specific substrates. Its function is particularly significant in the formation of complex carbohydrate structures, including branched N-glycans and specific glycan motifs that are essential for cell signaling, immune responses, and developmental processes. Research into B3GNT7 has gained momentum due to its implications in various biological processes and disease states, including cancer metastasis, where altered glycosylation patterns can influence tumor cell behavior and immune evasion mechanisms. Furthermore, aberrant expression of B3GNT7 has been linked to certain pathological conditions, highlighting its potential as a therapeutic target or biomarker. The production and characterization of recombinant B3GNT7 proteins allow for detailed investigation of its enzymatic properties, substrate specificity, and regulatory mechanisms, which are crucial for understanding its role in health and disease. Advances in recombinant DNA technology and protein expression systems have facilitated the purification and functional analysis of B3GNT7, paving the way for novel insights into its contribution to glycan diversity and its potential applications in biomedical research. As researchers continue to unravel the complexities of glycosylation, B3GNT7 stands out as a significant player in the intricate network of cellular interactions and functions, making it a valuable focus for continued exploration in glycobiology.